Azelastine Hydrochloride | EP | Reference Standards | EDQM | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Azelastine Hydrochloride
EDQM

PharmaCompass Sponsored Ads

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Azelastine Hydrochloride

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

25 API Suppliers, 14 USDMF, 7 CEP/COS, 2 JDMF, 4 EU WC, 14 KDMF, 14 NDC API, 12 Listed Suppliers, $ API Reference Price

25 API Suppliers
14 USDMF
7 CEP/COS
2 JDMF
4 EU WC
14 KDMF
14 NDC API
12 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

2 Drugs in Development

2 Drugs in Development

INTERMEDIATES

3 Intermediate Suppliers

3 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

83 FDF Dossiers, 39 FDA Orange Book, 27 Europe, 3 Canada, 2 South Africa, 12 Listed Dossiers

83 FDF Dossiers
39 FDA Orange Book
27 Europe
3 Canada
2 South Africa
12 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SPRAY, METERED;NASAL - 0.137MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SPRAY, METERED;NASAL - 0.137MG/SPRAY;0.05MG/SPRAY, SOLUTION/DROPS;OPHTHALMIC - 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SPRAY, METERED;NASAL - 0.137MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SPRAY, METERED;NASAL - 0.137MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
SPRAY, METERED;NASAL - 0.137MG/SPRAY;0.05MG/SPRAY
SOLUTION/DROPS;OPHTHALMIC - 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
SPRAY, METERED;NASAL - 0.137MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 3 Rochem International Inc, 3 SPI Pharma, 1 DKSH, 1 Pharm-RX Chemical, 1 Faran Shimi Pharmaceutical, 4 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 1 ACG Worldwide, 11 Actylis, 2 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 BASF, 1 Bioplus Life Sciences, 10 Corel Pharma Chem, 2 DFE Pharma, 1 Finar, 8 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 15 Kerry, 4 Kima Chemical, 6 Lonza Capsugel, 6 Microlex e.U, 1 Nanjing Bold Chemical, 1 Novo Excipients, 1 Pharmatrans-Sanaq, 2 Pluviaendo, 1 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 18 Roquette, 12 Seppic, 2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 8 Sigachi Industries, 3 The Dow Chemical Company, 1 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

45 Coating Systems & Additives, 22 Fillers, Diluents & Binders, 21 Controlled & Modified Release, 18 Film Formers & Plasticizers, 16 Solubilizers, 16 Thickeners and Stabilizers, 15 Parenteral, 11 Direct Compression, 10 Taste Masking, 7 Co-Processed Excipients, 7 Granulation, 6 Disintegrants & Superdisintegrants, 6 Rheology Modifiers, 5 Chewable & Orodispersible Aids, 5 Empty Capsules, 5 Topical, 4 Vegetarian Capsules, 4 API Stability Enhancers, 4 Emulsifying Agents, 2 Surfactant & Foaming Agents, 2 Coloring Agents, 1 Lubricants & Glidants, 1 Soft Gelatin

45 Coating Systems & Additives
22 Fillers, Diluents & Binders
21 Controlled & Modified Release
18 Film Formers & Plasticizers
16 Solubilizers
16 Thickeners and Stabilizers
15 Parenteral
11 Direct Compression
10 Taste Masking
7 Co-Processed Excipients
7 Granulation
6 Disintegrants & Superdisintegrants
6 Rheology Modifiers
5 Chewable & Orodispersible Aids
5 Empty Capsules
5 Topical
4 Vegetarian Capsules
4 API Stability Enhancers
4 Emulsifying Agents
2 Surfactant & Foaming Agents
2 Coloring Agents
1 Lubricants & Glidants
1 Soft Gelatin

DIGITAL CONTENT

35 NEWS #PharmaBuzz

35 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 20 Finished Drug Prices, 2 Annual Reports

1 US Medicaid Prescriptions
20 Finished Drug Prices
2 Annual Reports

MARKET PLACE

16 APIs, 1 FDF Dossiers

16 APIs
1 FDF Dossiers

PATENTS & EXCLUSIVITIES

14 US Patents

14 US Patents

REF. STANDARDS & IMPURITIES

4 EDQM, 4 USP, 13 Others

4 EDQM
4 USP
13 Others

$ API Ref.Price (USD/KG) : 8,541 Xls

Filters

Reset all filters

Filters

FILTER :

filter Order Code Reset all filters

4 All

01 1Y0000326

02 1Y0000327

03 1Y0000328

04 1Y0000329

filter CAS Number Reset all filters

4 All

01 179307-93-0

02 3n/a

filter Reference Standard Reset all filters

4 All

01 1Azelastine hydrochloride

02 1Azelastine impurity B

03 1Azelastine impurity D

04 1Azelastine impurity E

Coral Drugs Azelastine Hydrochloride

Product Main Page

01

EDQM, Council of Europe

Azelastine impurity E

BioAsia

Not Confirmed

EDQM, Council of Europe

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Azelastine impurity E

CAS Number : n/a

Quantity Per Vial : 5 mg

Sale Unit : 1

Order Code : Y0000329

Batch No : 1

Price (€) : 79

Storage : +5°C ± 3°C

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

EDQM, Council of Europe

Azelastine impurity D

BioAsia

Not Confirmed

EDQM, Council of Europe

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Azelastine impurity D

CAS Number : n/a

Quantity Per Vial : 5 mg

Sale Unit : 1

Order Code : Y0000328

Batch No : 1

Price (€) : 79

Storage : +5°C ± 3°C

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

EDQM, Council of Europe

Azelastine impurity B

BioAsia

Not Confirmed

EDQM, Council of Europe

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Azelastine impurity B

CAS Number : n/a

Quantity Per Vial : 5 mg

Sale Unit : 1

Order Code : Y0000327

Batch No : 1

Price (€) : 79

Storage : +5°C ± 3°C

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

EDQM, Council of Europe

Azelastine hydrochloride

BioAsia

Not Confirmed

EDQM, Council of Europe

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Azelastine hydrochloride

CAS Number : 79307-93-0

Quantity Per Vial : 25 mg

Sale Unit : 1

Order Code : Y0000326

Batch No : 1

Price (€) : 79

Storage : +5°C ± 3°C

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US!